Sun Pharmaceutical Industries Limited — Others, 28-11-2024: Action(s) taken or orders passed

Sun Pharmaceutical Industries Limited has received orders from the Regional Director of the Ministry of Corporate Affairs regarding compounding offences for alleged violations of the Companies Act. A total compounding fee of INR 36.5 lakh (cr) has been levied on past and present directors, including Mr. Dilip Shanghvi and Mr. Sudhir Valia. Despite these developments, there is no significant impact on the company’s operations or finances. While the situation may raise investor concerns regarding governance, the company has taken corrective measures in subsequent periods by properly disclosing related party transactions, which might enhance investor confidence moving forward.